Analysts expect Novartis Ag to report revenue of 13.73 B for Q3 26, against a range of 12.87 B to 14.59 B. The most recent reported quarter, Q2 26, came in at 14.41 B, a 1.8% miss against the 14.68 B consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 12.82 B | 13.15 B | 13.23 B | 14.05 B | 13.91 B | 13.34 B | 13.11 B | 14.41 B | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 12.92 B | 12.99 B | 13.78 B | 14.29 B | 15.27 B | 15.08 B | 13.10 B | 15.56 B | 14.59 B | 16.86 B | 16.27 B | 15.74 B | 16.16 B | 16.06 B | 16.71 B | 18.60 B | ||||||||||
| Low Estimate | 11.66 B | 10.92 B | 11.29 B | 11.93 B | 13.98 B | 13.72 B | 12.13 B | 13.80 B | 12.87 B | 13.83 B | 13.57 B | 14.16 B | 13.23 B | 14.57 B | 15.57 B | 15.88 B | ||||||||||
| Consensus Estimate | 12.29 B | 11.95 B | 12.53 B | 13.11 B | 14.63 B | 14.40 B | 12.61 B | 14.68 B | 13.73 B | 15.35 B | 14.92 B | 14.95 B | 14.70 B | 15.31 B | 16.14 B | 17.24 B |
Analysts expect Novartis Ag to report earnings per share of 2.19 for Q3 26, against a range of 2.06 to 2.32. The most recent reported quarter, Q2 26, came in at 2.41, a 5.2% beat against the 2.29 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 2.06 | 1.98 | 2.28 | 2.42 | 2.25 | 2.03 | 1.99 | 2.41 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 2.08 | 1.88 | 2.19 | 2.51 | 2.48 | 2.06 | 2.14 | 2.36 | 2.32 | 2.18 | 2.48 | 2.90 | 2.83 | 2.59 | 2.88 | 3.42 | ||||||||||
| Low Estimate | 1.88 | 1.62 | 1.79 | 2.29 | 2.24 | 1.74 | 1.92 | 2.22 | 2.06 | 1.98 | 2.04 | 2.54 | 2.31 | 2.27 | 2.62 | 2.80 | ||||||||||
| Consensus Estimate | 1.98 | 1.75 | 1.99 | 2.40 | 2.36 | 1.90 | 2.03 | 2.29 | 2.19 | 2.08 | 2.26 | 2.72 | 2.57 | 2.43 | 2.75 | 3.11 |
Pull Wall Street consensus for Novartis Ag (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=NVS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "NVS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=NVS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();